KY MPJE flashcards
KY MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Pharmacist-in-charge duties
- The Kentucky pharmacist-in-charge is accountable for the pharmacy's compliance with statutes and Board rules, including recordkeeping, security, technician supervision, staffing adequacy, and quality improvement activities.
- Continuous quality improvement program
- Kentucky pharmacies must maintain a documented CQI program that records dispensing errors and near misses, analyzes underlying causes, and implements changes intended to prevent recurrence.
- Pharmacist on duty rule
- A Kentucky pharmacy may not operate without a licensed pharmacist present and supervising; technicians cannot lawfully perform dispensing functions when no pharmacist is on duty.
- Records ready for inspection
- Prescription, controlled substance, and purchasing records must be readily retrievable and produced on request during a Kentucky Board of Pharmacy inspection; DEA records must be kept two years.
- NAPLEX and MPJE required
- To be licensed in Kentucky, a candidate must pass the NAPLEX and the Multistate Pharmacy Jurisprudence Examination, complete an accredited degree, and document the required internship hours.
- Pharmacy technician registration
- Kentucky requires a person to hold Board of Pharmacy registration before performing technician duties; national certification is a separate credential and does not replace state registration.
- Continuing education attestation
- At each Kentucky license renewal, the pharmacist attests to completing the Board-required continuing education hours for that cycle; incomplete or false attestation can lead to discipline.
- Pharmacy intern registration
- Students must register with the Kentucky Board of Pharmacy before accrued internship hours count toward licensure, and intern activity must occur under pharmacist supervision.
- Kentucky generic substitution
- A Kentucky pharmacist may substitute a federally rated therapeutically equivalent product unless the prescriber indicates dispense as written; the patient must be informed of the substitution.
- Prospective drug utilization review
- Before dispensing, the pharmacist screens the new prescription against the patient profile for allergies, interactions, duplication, dosing errors, and contraindications, and resolves identified problems with the prescriber.
- Prescription transfer documentation
- Transfers occur pharmacist-to-pharmacist between licensed pharmacies and must record both pharmacies' names, the transferring pharmacist, the date, and refills remaining; Schedule II transfers are tightly restricted.
- Prescription label elements
- Kentucky labels must show pharmacy name and address, prescription number, date, patient name, directions, prescriber, drug name and strength, quantity, refills, expiration or beyond-use date, and pharmacist initials.
- KASPER reporting
- KASPER is Kentucky's controlled substance prescription monitoring program; dispensers must report each controlled substance dispensing, and authorized prescribers and pharmacists may query patient histories.
- Electronic prescribing mandate
- Kentucky requires controlled substance prescriptions to be transmitted electronically, subject to statutory exceptions such as system failure, technical limitation, or an approved waiver.
- Emergency oral Schedule II
- An oral emergency Schedule II order may supply no more than seven days, and the prescriber must deliver a written or electronic prescription within seven days or the pharmacist must notify DEA.
- Partial fill of Schedule II
- A Schedule II prescription may be partially filled; unless the patient is in a long-term care facility or terminally ill, the remainder must be supplied within 72 hours or the prescription lapses.
- Offer to counsel
- Kentucky requires the pharmacist to offer counseling for each new prescription; the patient may decline, and the offer and any refusal should be documented in the record.
- Counseling content elements
- Counseling covers drug name and description, dose, route, frequency, duration, special directions, storage, refills, common side effects, interactions, precautions, and self-monitoring expectations.
- Counseling by pharmacist only
- Only the pharmacist may provide required prescription counseling; technicians and clerks may hand out written materials but cannot substitute for the pharmacist's counseling offer.
- Opioid counseling points
- When dispensing opioids, pharmacists counsel on dependence risk, avoiding alcohol and benzodiazepines, secure storage, proper disposal, and availability of naloxone for overdose reversal.
- Beyond-use date
- The beyond-use date is the last date a compounded or repackaged preparation may be used, calculated from the preparation date using USP limits based on water content, preservatives, and storage.
- High-alert medications
- High-alert drugs carry elevated risk of harmful error; safeguards include independent double checks, standardized concentrations, limited-access storage, and tall-man lettering for look-alike names.
- MedWatch reporting
- MedWatch is the FDA voluntary reporting system for serious adverse events, product quality defects, and medication errors; reporting by pharmacists is encouraged but generally not mandatory.
- Recall handling
- On receiving a drug recall notice, the pharmacy identifies and quarantines affected stock, contacts patients when instructed, documents the action, and returns product per the notice.
- DEA Form 106
- A registrant discovering theft or significant loss of controlled substances must notify DEA using Form 106 within one business day of discovery and also notify state authorities.
- Biennial inventory
- Every DEA registrant counts all controlled substances on hand at least every two years, records the count with date and signature, and retains the inventory for two years.
- DEA Form 222
- Form 222, or its electronic CSOS equivalent, is the order document required to obtain Schedule II substances; a power of attorney authorizes named employees to sign orders.
- Reverse distributor disposal
- Expired or unwanted controlled substances are transferred to a DEA-registered reverse distributor with a record of the transfer kept; on-site destruction requires DEA Form 41.
- Naloxone without prescription
- Kentucky pharmacists may dispense naloxone without a patient-specific prescription under a physician-approved protocol and must counsel the recipient on recognizing overdose and administering the product.
- Pharmacist immunization authority
- Kentucky pharmacists who hold current CPR certification and completed ACPE-accredited immunization training may administer vaccines under a protocol with a prescribing physician.
- Vaccine information statement
- Federal law requires that the current vaccine information statement be given to the patient or guardian before each dose of a covered vaccine, with the edition date documented.
- Immunization documentation
- Each administered dose must be recorded with vaccine name, manufacturer, lot, expiration, dose, site, route, date, administering pharmacist, and the VIS edition date given.